Stock Taper
EXCHANGE TRADED FUND

FFTY

CapForce IBD 50 ETF
$36.58 ▼ 1.85%
−$0.69 TODAY

FUND FACTS

Manager Capital Force
Assets $89.4M
Expense ratio 0.80%
Inception Apr 8, 2015
Asset class Equity
Holdings 48
Volume 18.56K
Avg volume 35.53K

ABOUT THIS FUND

CapForce IBD 50 ETF seeks to track the investment results of the IBD 50 Index. IBD 50 is Investor's Business Daily's signature investing tool—targeting companies that are generating outstanding profit growth, big sales increases, wide profit margins and a high return on equity.

PRICE

$36.58 ▼ DOWN 1.85% (−$0.69)
$36.50$36.75$37.009:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM36.58

HOLDINGS

TOP 20 OF 48 · 63.64% OF THE FUND
RANK STOCK WEIGHT SHARES VALUE
01 DAVE Dave Inc. 3.60% 7.1K $2.75M
03 ERO Ero Copper Corp. 3.50% 67.4K $2.67M
04 WT WisdomTree, Inc. 3.49% 106.82K $2.67M
05 TGTX TG Therapeutics, Inc. 3.47% 48.06K $2.65M
06 TVTX Travere Therapeutics, Inc. 3.46% 39.41K $2.64M
07 NTRA Natera, Inc. 3.41% 7.81K $2.6M
08 HNGE Hinge Health, Inc. 3.41% 29.22K $2.6M
09 ETON Eton Pharmaceuticals, Inc. 3.38% 42.24K $2.58M
10 AUGO Aura Minerals 3.35% 29.62K $2.56M
11 SN SharkNinja, Inc. 3.07% 12.02K $2.34M
12 GKOS Glaukos Corporation 3.02% 12.55K $2.31M
13 ATI ATI Inc. 3.00% 10.65K $2.29M
14 LIFE Ethos Technologies Inc. 3.00% 57.97K $2.29M
15 EXPE Expedia Group, Inc. 2.99% 6.8K $2.28M
16 HALO Halozyme Therapeutics, Inc. 2.98% 21.18K $2.28M
18 OSCR Oscar Health, Inc. 2.96% 72.57K $2.26M
19 URGN UroGen Pharma Ltd. 2.88% 49.35K $2.2M
20 ZETA Zeta Global Holdings Corp. 2.19% 53.54K $1.67M

SECTOR HOLDINGS

TECHNOLOGY IS 40.62% OF THE FUND
Healthcare 40.62%
Technology 22.15%
Financial Services 13.22%
Consumer Cyclical 8.48%
Industrials 6.49%
Basic Materials 6.11%
Energy 1.98%
Communication Services 0.97%

BY REGION

UNITED STATES IS 83.13% OF THE FUND
United States 83.13%
United Kingdom 3.63%
Greece 3.16%
Cayman Islands 3.12%
Canada 2.06%
Switzerland 1.95%
Japan 1.01%
Israel 0.52%
Taiwan 0.50%
Netherlands 0.50%
Other 0.43%